Below are the most recent publications written about "Saphenous Vein" by people in Profiles.
-
Hussain MA, Khan AA, Menard MT, Conte MS, Vouyouka AG, Doros G, Strong MB, Kalish JA, Chew D, Gasper WJ, Tan TW, Darling RC, LaMuraglia G, Rosenfield K, Farber A, Schanzer A. Contemporary outcomes of lower extremity vein bypass for chronic limb-threatening ischemia based on a post hoc comparison of the BEST-CLI and PREVENT III multicenter prospective randomized controlled trials. J Vasc Surg. 2026 04; 83(4):1171-1180.
-
Conte MS, Farber A, Barleben A, Chisci E, Doros G, Kashyap VS, Kayssi A, Kolh P, Moreira CC, Nypaver T, Rosenfield K, Rowe VL, Schanzer A, Singh N, Siracuse JJ, Strong MB, Menard MT. Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia. Circ Cardiovasc Interv. 2025 Mar; 18(3):e014716.
-
Ulloa JG, Alabi O, McGinigle K, Lane J, Doros G, Menard M, Moreira CC, Judelson DR, Farber A, Conte MS, Rosenfeld K, Hamouda M, Kirksey L, Strong MB, Malas M, Kernodle A, Rowe VL. Outcomes for Hispanic patients undergoing open bypass in BEST-CLI. J Vasc Surg. 2025 06; 81(6):1420-1429.
-
Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Doros G, Motaganahalli R, Laskowski IJ, Barshes NR, Genovese EA, Strong MB, Mills JL. Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial. J Vasc Surg. 2025 03; 81(3):720-729.e1.
-
Farber A, Menard MT, Conte MS, Rosenfield K, Schermerhorn M, Schanzer A, Powell RJ, Chaar CIO, Hicks CW, Doros G, Strong MB, Leers SA, Motaganahalli R, Stangenberg L, Siracuse JJ. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025 02; 81(2):408-416.e2.
-
Venermo MA, Farber A, Schanzer A, Menard MT, Rosenfield K, Dosluoglu H, Goodney PP, Abou-Zamzam AM, Motaganahalli R, Doros G, Creager MA. Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial. Eur J Vasc Endovasc Surg. 2024 Nov; 68(5):590-597.
-
Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, Hamza TH, Assmann SF, Creager MA, Cziraky MJ, Dake MD, Jaff MR, Reid D, Siami FS, Sopko G, White CJ, van Over M, Strong MB, Villarreal MF, McKean M, Azene E, Azarbal A, Barleben A, Chew DK, Clavijo LC, Douville Y, Findeiss L, Garg N, Gasper W, Giles KA, Goodney PP, Hawkins BM, Herman CR, Kalish JA, Koopmann MC, Laskowski IA, Mena-Hurtado C, Motaganahalli R, Rowe VL, Schanzer A, Schneider PA, Siracuse JJ, Venermo M, Rosenfield K. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med. 2022 12 22; 387(25):2305-2316.
-
Hays NM, Balsam LB. Commentary: Prevention of saphenous vein graft disease remains elusive. J Card Surg. 2022 Mar; 37(3):571-573.
-
Li N, Ferracane J, Andeen N, Lewis S, Woltjer R, Rugonyi S, Jahangiri Y, Uchida B, Farsad K, Kaufman JA, Al-Hakim RA. Endovascular Venous Stenosis and Thrombosis Large Animal Model: Angiographic, Histological, and Biomechanical Characterizations. J Vasc Interv Radiol. 2022 03; 33(3):255-261.e2.
-
Dalmia V, Carnevale M, Friedmann P, Indes J, Lipsitz E, Futchko J, Koleilat I. Impact of tibial bypass conduit on long-term amputation-free survival and primary patency in the Vascular Quality Initiative. J Vasc Surg. 2022 04; 75(4):1351-1357.e2.